THE INCIDENCE and clinical significance of repetitive ventricular responses (RVR) to single ventricular extrastimuli during normal sinus rhythm (NSR) or atrial pacing has stimulated considerable interest and debate.` 6 Recently, Greene and co-workers reported a high (> 85%) incidence of RVR in patients with a history of recurrent ventricular tachycardia (VT).1'" Their findings suggested that the suppression of RVR might constitute a useful end point to guide the selection of long-term prophylactic antiarrhythmic drug therapy.2 The purpose of this study was to assess the incidence of RVR and to compare the sensitivity of this finding with that of electrically stimulated VT in three populations of patients with serious ventricular arrhythmias.
Electrophysiologic studies were carried out in 85 patients who were referred for the management of serious ventricular arrhythmias. Sixty-four males and 21 females, mean age 56 years (range 19-75 years), were studied. Sixty-three patients had coronary artery disease, 10 had valvular heart disease, and eight had primary myocardial disease. Four patients had no detectable evidence of structural heart disease. The patients were divided into three groups, based on the rhythm disturbance for which they were referred. Group A included 44 patients with a history of recurrent (two to 80) episodes of symptomatic sustained VT that required drug therapy or cardioversion for termination. VT was associated with loss of consciousness in 21 patients and with presyncope, congestive heart failure or angina pectoris in 23. Group B included 16 patients with recurrent episodes of symptomatic nonsustained VT (. 5 beats) that were associated with syncope in seven patients and presyncope or palpitations in nine patients. Group C included 25 patients who had survived at least one episode of prehospital ventricular fibrillation (VF). None of the 85 patients had evidence of acute myocardial infarction associated with their arrhythmias or within 3 months before referral for electrophysiologic study.
Each patient gave informed consent. Electrophysiologic procedures were performed with the patient in a fasting, nonsedated state. Antiarrhythmic drugs were discontinued under continuous ECG monitoring at least 48 hours before the time of electrophysiologic study. Digitalis therapy was continued for treatment of congestive heart failure. Three or four quadripolar electrode catheters with a 1-cm interelectrode distance were inserted percutaneously through the femoral veins or through one or more antecubital veins and were positioned under fluoroscopic guidance at multiple intracardiac sites. Catheter positions included the lateral right atrium, the atrioventricular junction for recording electrical activity from the region of the bundle of His, and the right ventricular apex in all patients. In nine patients, a catheter was also positioned in the coronary sinus. The distal pair of electrodes on each catheter was used for stimulation and the proximal pair for recording of local electrograms.
Intracardiac recordings were filtered at 30-500 Hz and displayed simultaneously with surface ECG leads 1, 2 and V, on a multichannel oscilloscope (Electronics for Medicine VR-16). Data were stored on FM magnetic tape (A.R. Vetter Co.) and later retrieved on photographic paper at speeds of 100-200 mm/sec. Cardiac stimulation was performed with a programmable constant-current stimulator (Medtronic 5325) that delivered rectangular 2-msec pulses. All ventricular stimulation was carried out from the right ventricular apex at twice diastolic threshold (< 2 mA).
The following stimulation protocol was used in all 85 patients: (1) These disparate observations probably cannot be explained on the basis of differences in the stimulation protocols. In our study, all programmed stimulation was performed from the right ventricular apex, because we have found that other catheter positions within the right ventricle lack sufficient stability and reproducibility for serial antiarrhythmic drug testing. Greene 196 of 221 patients in the series reported by Greene and coworkers.3 Differences in the patient populations are also unlikely to account for the disparate observations on the incidence of RVR in the two series. Of the 85 patients in our series, 44 had a history of symptomatic sustained VT, 16 had symptomatic nonsustained VT, and 25 patients had survived at least one episode of out-of-hospital ventricular fibrillation. Of the patients studied by Greene and co-workers, the largest group included 102 patients with symptomatic ventricular tachycardia. 3 The clinical characteristics of the patients with VT in both studies were quite similar.3 During RVR testing, we encountered several types of wide QRS-complex responses that might lead to an overestimation of the true incidence of RVR as defined in this and earlier studies (i.e., intraventricular reentry 
Clinical Implications
We conclude from our own observations in 85 patients, and those of others in comparable numbers of patients, that RVRs after single ventricular extrastimuli delivered during normal sinus rhythm or atrial pacing are present in approximately 15% of patients with a history of VT or VF unassociated with acute myocardial infarction.4' 5 Thus, although the specificity of these responses must be studied, RVR testing as defined in this and previous studies is an extremely insensitive index of susceptibility to serious ventricular arrhythmias. In contrast, programmed premature ventricular stimulation during ventricular pacing, as well as brief bursts of rapid ventricular pacing, results in the reproducible initiation of sustained or nonsustained ventricular tachycardia in 75-90% of patients with a history of VT or VF.12~16 Furthermore, the suppression of electrically inducible VT with antiarrhythmic drugs is highly predictive of a successful clinical response at 1-2 years of follow-up in these patients. Thus, we believe that the suppression of inducible VT is the most sensitive and reliable therapeutic end point.
